Francis S. Willard

Statistics

Publications

Citations

5.8K

H-Index

Active since

2000

Affiliations

University of North Carolina at Chapel Hill(Current)

Eli Lilly (United States)

UNC Lineberger Comprehensive Cancer Center

Australian National University

Eli Lilly (Spain)

Francis S. Willard is an author at University of North Carolina at Chapel Hill specializing in life sciences, cell signaling, and signal transduction.

ORCID

Publications per year

2000–2024

Publications

Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist

Francis S. Willard, Jonathan D. Douros, M Gabe et al. · JCI Insight · 2020 · 487 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Crystal structure of the human PRMT5:MEP50 complex

Stephen Antonysamy, Zahid Bonday, Robert M. Campbell et al. · Proceedings of the National Academy of Sciences · 2012 · 363 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

A Seven-Transmembrane RGS Protein That Modulates Plant Cell Proliferation

Jin‐Gui Chen, Francis S. Willard, Jirong Huang et al. · Science · 2003 · 331 citations

Life Sciences, Plant Biology, Plant Sciences +17

Translation of Polarity Cues into Asymmetric Spindle Positioning in <i>Caenorhabditis elegans</i> Embryos

Kelly Colombo, Stephan W. Grill, Randall J. Kimple et al. · Science · 2003 · 298 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +16

LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept

Tamer Coşkun, Shweta Urva, William C. Roell et al. · Cell Metabolism · 2022 · 276 citations · Full text

Medicine, Endocrinology, Pharmacology +17

1–5 of 69